Please login to the form below

Not currently logged in
Email:
Password:

US recall of four children's products

Blacksmiths Brands has announced the recall of four children's products in the PediaCare line in the US

Blacksmiths Brands has announced the recall of four children's products in the PediaCare line in the US.

The voluntary recall comes after consultation with the US Food and Drug Administration (FDA) in what Blacksmiths Brands described as a 'precautionary step'.

The products had all been manufactured at the McNeil Consumer Healthcare Fort Washington, Pennsylvania, which has been temporarily shut down following an FDA inspection that found serious violations of the agency's good manufacturing practice requirements. McNeil Consumer Healthcare is a subsidiary of Johnson & Johnson.

The products involved in the recall are PediaCare Multi-Symptom Cold 4oz, PediaCare Long Acting Cough 4oz, PediaCare Decongestant 4oz and PediaCare Allergy and Cold 4oz.

In a statement, the company said: "the recall was not initiated as a result of any consumer reports of adverse events and no consumer complaints have been received about the safety or purity of the products."

Blacksmiths Brands have however advised customers who own any of the recalled products to dispose of them.

Peter Man, chairman and CEO of the company, said: "We're taking this voluntary step because protecting consumers and maintaining their trust are essential to our company's core values."

New arrangements for the manufacture of the recalled products have been made, with shipments expected to resume in July.

1st June 2010

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Random42 Scientific Communication

Random42 is the world's leading medical animation company. Over the past 25 years we have produced core digital assets for...

Latest intelligence

Is the pharma business model ready for precision medicine?
Precision medicine promises to revolutionise patient outcomes and reduce costs for industry but is pharma ready for it? Blue Latitude Health co-founder Head of Strategy Fred Bassett explores the challenges...
ABPI2018
The NHS and ABPI at 70: inching closer to the triple win
The NHS and UK pharma’s ABPI both turn 70 this year. After years of transactional relationships, there’s a will to work more closely - but friction on prices and value...
What pharma marketers can learn from behavioural science
Pharma behavioural science and traditional emotional marketing create a powerful mix of techniques that have impact on real lives....

Infographics